author-photo

Kimberly H. Harrington

Fred Hutchinson Cancer Research Center

21

Papers

717

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (8)
Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (32)
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia.

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (58)
T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330.

2015 Blood Cancer Journal
Show All
- Source
- Cite
- Save
Citations (45)
High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

2015 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (32)
Construction and characterization of novel CD33/CD3 tandem diabodies (TandAbs) for the treatment of acute myeloid leukemia (AML).

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Multimerin-1 (MMRN1) As Novel Adverse Prognostic Marker in Acute Myeloid Leukemia: A Report from the Children’s Oncology Group

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Heterogeneity of Clonal Expansion and Maturation-Linked Mutation Acquisition in Hematopoietic Progenitors in Human Acute Myeloid Leukemia

2014 Leukemia
Show All
- Source
- Cite
- Save
Citations (9)
AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin

2013 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (29)